What is the market cap of Vineet Laboratories Ltd?

As of 02/04/2026, the market cap of Vineet Laboratories Ltd stands at ₹55.70 Cr.

What is the PE and PB ratio of Vineet Laboratories Ltd?

The PE and PB ratios of Vineet Laboratories Ltd is -5.68 ratio and 23 ratio as of 02/04/2026.

What is the 52 week high and low of Vineet Laboratories Ltd?

The 52 week high and low of Vineet Laboratories Ltd is ₹42.19 and ₹22.37 as of 02/04/2026.

How can I buy Vineet Laboratories Ltd share?

You can easily buy Vineet Laboratories Ltd shares on the Bajaj Broking platform by opening a Demat account and verifying your KYC documents online. There are no account opening charges for a Demat account with Bajaj Broking.

What determines a company’s share price?

A company’s share price is determined by supply and demand dynamics in the stock market. Factors influencing it include the company’s financial performance, earnings growth, revenue, and profitability, as well as broader economic conditions, market sentiment, and investor perception. Other determinants include sector trends, government policies, interest rates, and global events. Positive news or growth prospects can drive demand and raise the share price, while negative developments can push it lower. Analysts’ recommendations, institutional buying or selling, and technical factors such as trading volume also influence price movements. Ultimately, the share price reflects the market’s collective view of a company’s current and future value.

What is the “last sale,” “bid,” and “ask” price of Vineet Laboratories Ltd?

The “last sale” is the most recent price at which a stock, like Vineet Laboratories Ltd , was traded. The “bid” price represents the highest price buyers are willing to pay, while the “ask” price is the lowest price sellers are ready to accept. The difference between the bid and ask is known as the spread. Monitoring these prices helps investors understand market sentiment and liquidity. For example, a narrow spread indicates high liquidity and active trading, while a wide spread may suggest lower activity or higher volatility. These metrics are crucial for executing timely buy or sell orders in the stock market.

How to read share price charts for Vineet Laboratories Ltd?

Share price charts display the historical price movement of Vineet Laboratories Ltd , helping investors analyse trends, patterns, and potential entry or exit points. Charts typically show candlestick patterns, line graphs, or bar charts, representing open, high, low, and close prices. Key indicators include moving averages, support and resistance levels, and trading volume. Candlestick patterns can reveal bullish or bearish trends, while volume confirms the strength of price movements. Investors can use charts for technical analysis to assess momentum, predict short-term fluctuations, or complement fundamental analysis for long-term decisions. Understanding trends over daily, weekly, or monthly periods helps in making informed trading and investment choices.

What is volatility, and how does it affect share price movement for Vineet Laboratories Ltd?

Volatility measures the degree of price fluctuations of a stock over time. High volatility indicates that Vineet Laboratories Ltd share price can experience large swings in short periods, while low volatility suggests stable prices. Factors causing volatility include market sentiment, earnings announcements, global events, economic indicators, and industry news. High volatility can create opportunities for traders to profit from rapid price changes but also increases risk for long-term investors. Understanding volatility helps investors manage risk, set stop-loss limits, and determine the appropriate investment horizon based on their risk tolerance.

VINEET LABORATORIES LTD

VINEETLAB

Small Cap | Pharmaceuticals

₹29.5

+0.03 (+0.1%)

‌

Stock price as on 02 Apr 2026 at 15:29 PM

Vineet laboratories ltd share price update

As of the latest trading session, Vineet Laboratories Ltd share price is currently at ₹29.5, which is up by ₹0.03 from its previous closing. Today the...

Vineet Laboratories Ltd stock performance

Today’s low

₹29.32

Today’s high

₹30.21

₹29.5

52 week low

₹22.37

52 week high

₹42.19

₹29.5

Open

₹29.52

Previous close

₹29.47

Share volume

1,24,150

Total traded value (Lakh)

₹36.01

Upper circuit

₹35.36

Lower circuit

₹23.58

Vineet Laboratories Ltd fundamentals

Market cap (Cr)

₹55.70

P/E ratio (TTM)

-5.68

Book value per share

₹23.00

Beta

0.72

Return on equity

Earnings per share (TTM)

₹0.00

Dividend yield

Net profit/quarter (Cr)

₹0.85

Vineet Laboratories Ltd financials

(Values in Cr)

Revenue

Net income

Particulars	Dec 25 (₹ value in crores)
Revenue	₹15.65
Operating expense	₹14.87
Net income	₹0.85
Net profit margin	5.43%
Earning per share	₹0.92
EBITDA	₹2.54
Effective tax rate	-3.65%

Particulars	Sep 25 (₹ value in crores)
Revenue	₹17.42
Operating expense	₹17.06
Net income	₹0.40
Net profit margin	2.29%
Earning per share	₹0.43
EBITDA	₹3.19
Effective tax rate	-8.1%

Particulars	Jun 25 (₹ value in crores)
Revenue	₹7.44
Operating expense	₹8.36
Net income	-₹0.87
Net profit margin	-11.69%
Earning per share	-₹0.94
EBITDA	₹0.33
Effective tax rate	4.44%

Particulars	Mar 25 (₹ value in crores)
Revenue	₹14.08
Operating expense	₹26.68
Net income	-₹10.53
Net profit margin	-74.78%
Earning per share	-₹11.42
EBITDA	-₹9.66
Effective tax rate	6.23%

Particulars	Dec 24 (₹ value in crores)
Revenue	₹18.10
Operating expense	₹23.80
Net income	-₹5.71
Net profit margin	-31.54%
Earning per share	-₹6.19
EBITDA	-₹4.10
Effective tax rate	-0.52%

Particulars	Mar 25 (₹ value in crores)
Revenue	₹75.00
Operating expense	₹97.76
Net income	-₹20.19
Net profit margin	-26.91%
Earning per share	-₹21.90
EBITDA	-₹14.30
Effective tax rate	2.79%

Particulars	Mar 24 (₹ value in crores)
Revenue	₹150.59
Operating expense	₹150.69
Net income	₹1.03
Net profit margin	0.68%
Earning per share	₹1.11
EBITDA	₹7.66
Effective tax rate	-183.33%

Particulars	Mar 23 (₹ value in crores)
Revenue	₹212.29
Operating expense	₹210.39
Net income	₹1.25
Net profit margin	0.58%
Earning per share	₹1.36
EBITDA	₹7.78
Effective tax rate	38.42%

Particulars	Mar 22 (₹ value in crores)
Revenue	₹191.17
Operating expense	₹182.12
Net income	₹6.64
Net profit margin	3.47%
Earning per share	₹7.16
EBITDA	₹13.45
Effective tax rate	28.98%

Particulars	Mar 21 (₹ value in crores)
Revenue	₹243.48
Operating expense	₹239.80
Net income	₹1.78
Net profit margin	0.73%
Earning per share	₹2.18
EBITDA	₹8.54
Effective tax rate	56.15%

Particulars (annual)	Mar 25 (₹ value in crores)
Book value per share	₹15.89
Return on Equity (ROE)	-
Return on Capital Employed (ROCE)	-
Total debt to equity ratio	1.71
EBITDA margin	-19.05%

Particulars (annual)	Mar 24 (₹ value in crores)
Book value per share	₹37.67
Return on Equity (ROE)	2.31%
Return on Capital Employed (ROCE)	6.59%
Total debt to equity ratio	1.1
EBITDA margin	4.85%

Particulars (annual)	Mar 23 (₹ value in crores)
Book value per share	₹36.54
Return on Equity (ROE)	3.74%
Return on Capital Employed (ROCE)	8.51%
Total debt to equity ratio	0.86
EBITDA margin	3.66%

Particulars (annual)	Mar 22 (₹ value in crores)
Book value per share	₹36.03
Return on Equity (ROE)	22.19%
Return on Capital Employed (ROCE)	22.35%
Total debt to equity ratio	0.65
EBITDA margin	7.04%

Particulars (annual)	Mar 21 (₹ value in crores)
Book value per share	₹28.87
Return on Equity (ROE)	13.18%
Return on Capital Employed (ROCE)	32.64%
Total debt to equity ratio	0.46
EBITDA margin	3.51%

Particulars	Mar 25 (₹ value in crores)
Cash and short term investments	₹0.66
Total assets	₹94.54
Total liabilities	₹94.54
Total equity	₹14.64
Shares outstanding	₹0.92
Price to book ratio	₹1.92
Return on assets (%)	-21.35%
Return on capital	-36.92%

Particulars	Mar 24 (₹ value in crores)
Cash and short term investments	₹0.44
Total assets	₹116.87
Total liabilities	₹116.87
Total equity	₹34.72
Shares outstanding	₹0.92
Price to book ratio	₹1.31
Return on assets (%)	0.87%
Return on capital	1.3%

Particulars	Mar 23 (₹ value in crores)
Cash and short term investments	₹0.94
Total assets	₹115.84
Total liabilities	₹115.84
Total equity	₹33.68
Shares outstanding	₹0.92
Price to book ratio	₹1.12
Return on assets (%)	1.08%
Return on capital	1.93%

Particulars	Mar 22 (₹ value in crores)
Cash and short term investments	₹18.11
Total assets	₹133.31
Total liabilities	₹133.31
Total equity	₹33.21
Shares outstanding	₹0.92
Price to book ratio	₹1.32
Return on assets (%)	4.97%
Return on capital	11.11%

Particulars	Mar 21 (₹ value in crores)
Cash and short term investments	₹2.10
Total assets	₹108.74
Total liabilities	₹108.74
Total equity	₹26.61
Shares outstanding	₹0.92
Price to book ratio	-
Return on assets (%)	1.63%
Return on capital	4.55%

Particulars	Mar 25 (₹ value in crores)
Net income	-₹20.77
Cash from operations	₹11.61
Cash from investing	-₹3.18
Cash from financing	-₹8.23
Net change in cash	₹0.07
Free cash flow	₹12.65

Particulars	Mar 24 (₹ value in crores)
Net income	₹0.36
Cash from operations	-₹6.35
Cash from investing	-₹2.22
Cash from financing	₹8.42
Net change in cash	-₹0.40
Free cash flow	-₹3.56

Particulars	Mar 23 (₹ value in crores)
Net income	₹2.02
Cash from operations	-₹6.62
Cash from investing	-₹6.68
Cash from financing	₹0.27
Net change in cash	-₹16.02
Free cash flow	₹1.00

Particulars	Mar 22 (₹ value in crores)
Net income	₹9.34
Cash from operations	₹10.81
Cash from investing	-₹3.67
Cash from financing	₹11.95
Net change in cash	₹15.90
Free cash flow	₹10.81

Particulars	Mar 21 (₹ value in crores)
Net income	₹4.05
Cash from operations	₹26.63
Cash from investing	-₹7.80
Cash from financing	₹18.61
Net change in cash	₹38.29
Free cash flow	₹26.63

Company name	Price	P/E	P/B	Market cap	52 week low/high
AMBALAL SARABHAI ENTERPRISES L	₹28.41	12.3	1.47	₹217.72	₹23.12 / ₹42.00
BLISS GVS PHARMA LTD	₹201.65	19.28	1.88	₹2,133.23	₹105.05 / ₹244.05
CIPLA LTD	₹1,298.80	22.07	3.18	₹1,04,914.55	₹1,283.00 / ₹1,672.20
FERMENTA BIOTECH LIMITED	₹339.00	11.28	2.55	₹997.71	₹241.30 / ₹399.00
GLAXOSMITHKLINE PHARMACEUTICAL	₹2,405.15	40.51	23.85	₹40,744.69	₹2,220.00 / ₹3,515.95

Company name	Price	P/E	P/B	Market cap	52 week low/high
AMBALAL SARABHAI ENTERPRISES L	₹28.41	12.3	1.47	₹217.72	₹23.12 / ₹42.00
BLISS GVS PHARMA LTD	₹201.65	19.28	1.88	₹2,133.23	₹105.05 / ₹244.05
CIPLA LTD	₹1,298.80	22.07	3.18	₹1,04,914.55	₹1,283.00 / ₹1,672.20
FERMENTA BIOTECH LIMITED	₹339.00	11.28	2.55	₹997.71	₹241.30 / ₹399.00
GLAXOSMITHKLINE PHARMACEUTICAL	₹2,405.15	40.51	23.85	₹40,744.69	₹2,220.00 / ₹3,515.95

Vineet Laboratories Ltd technical summary

₹28.98

-2.88 ▼

Bearish

Bullish

5 Day29.9

10 Day30.2

12 Day30.3

20 Day30.6

26 Day30.9

50 Day31.9

100 Day32.6

200 Day33.2

Investment Returns

Over 1 Month2.83%▼

Over 3 Months16.83%▼

Over 6 Months0.47%▲

Over 1 Year9.26%▲

Vineet Laboratories Ltd Shareholding pattern

Public

94.01%

Promoter holdings

5.98%

FII

DII

Promoter shares

Promoter shares	Share	Category
Arjun Aggarwal	23,20,000 (12.08%)	Public Shareholding
Gaddam Venkata Ramana	4,71,600 (2.46%)	Shareholding of Promoter and Promoter Group
Rajesh Poddar	4,13,256 (2.15%)	Public Shareholding
Palloli Rama Chandra Reddy	3,56,715 (1.86%)	Public Shareholding
Sirisha Chintapalli	3,40,429 (1.77%)	Public Shareholding

About VINEET LABORATORIES LTD

Vineet Laboratories Limited, formerly known as Ortin Laboratories Limited is a manufacturing company of intermediates useful for the manufacture of active pharmaceutical ingredients. The Company was incorporated on 10 November 2016 and operates in the business of in the manufacture of Drug Intermediates & Bulk Dugs. The name of the Company changed to Vineet Laboratories Limited, on account of demerger in December, 2020. The production unit located at Malkapur Village, Yadadri- Bhuvanagiri District in Telangana State, India, is a multipurpose facility well equipped with stainless steel and glass-lined reactors with total volume of 230KL, of different volumes to suit any batch size. Special provisions are made to carry out reactions at very low temperature (up to -100°C). The Company is also specialized in manufacturing and handling pyrophoric chemicals like n-Butyl Lithium. The Company export the API intermediates, fine chemicals and custom synthesis molecules. The Company is interested in collaborating with exporters who want high quality products for export to other countries. In addition to the list of products enlisted in the website, the Company can manufacture as per customer requirements ,in case having any specific requirement. The Company constructed a warehouse with facilities for sampling both, dispensing booth, packing material room, rejected material room, intermediate room and a day storage for dispensed material 20 calibrated storage tanks from 10 KL to 40 KL available to store various solvents in dedicated tanks. All tanks are equipped with sprinklers and bund walls. The multipurpose facility of the Company is well equipped with stainless steel and glass-lined reactors with total volume of 230 KL, of different volumes to suit any batch size. These reactors are provided with primary and secondary condensers, azeotropic boxes with facility to continue distillation under vacuum. Special provisions are made to carry out reactions at very low temperature up to -100°C and under inert atmosphere like nitrogen. Special equipment is in place to carryout reactions at high temperatures up to 250°C. Molecular distillation at hundred kilo batch size can be carried out. The Company is also specialized in manufacturing and handling pyrophoric chemicals like n-Butyl Lithium. In 2020-21, the Company had two divisions - Formulations Division and API Intermediates Division. The erstwhile Company i.e. Ortin Laboratories Limited demerged the API Intermediates Division to the Company i.e. Vineet Laboratories Limited through the Scheme of Arrangement for Demerger in December, 2020. Company is associated with many domestic and overseas customers like Gilead Sciences, USA, Teva, Mylan Laboratories Ltd., Hyderabad, Orchid Chemicals And Pharmaceuticals Ltd., Hetero Drugs, Cipla Limited, Jubilant Organosys Ltd., etc.

Parent Organisation

Indian Private

NSE Symbol

VINEETLAB

Founded

2016

VINEET LABORATORIES LTD CORPORATE ACTION

Dividend date	Dividend amount	Dividend type	Record date	Instrument type
19 Sept 2022	1	Final	20 Sept 2022	Equity shares

View more stocks

sun pharmaceutical ind l

₹1,693.6

▼ 2.01%

divi s laboratories ltd

₹5,848.5

▼ 0.98%

torrent pharmaceuticals ltd.

₹3,987.2

▼ 3.01%

dr.reddys laboratories ltd.

₹1,217.3

▲ 0.63%

lupin ltd.

₹2,274.5

▼ 0.01%

cipla ltd

₹1,192.4

▼ 0.29%

zydus lifesciences limited

₹864.25

▲ 0.12%

What’s trending

All stocks

FRONTFN

FRONTLINE FINANCIAL SERVICES L

MOIL LIMITED

MANAS POLYMER N ENERGIE L

50.4

+8.4 (+20%)

GOKULAGRO

GOKUL AGRO RESOURCES LTD

191

+31.83 (+20%)

View all

Top gainers

HCL TECHNOLOGIES LTD

TECH MAHINDRA LIMITED

INFOSYS LIMITED

WIPRO LTD

Top losers

EICHER MOTORS LTD

ASIAN PAINTS LIMITED

ETERNAL LIMITED

SUN PHARMACEUTICAL IND L

1693.6

-34.90 (-2.02%)

View all

Frequently asked questions

 As of 02/04/2026, at 15:29 PM, the Vineet Laboratories Ltd share price stands at ₹29.5.

Related tags

Disclaimer

*Disclaimer for Bajaj Finance Limited (‘BFL’):

Stock trading business is carried by Bajaj Financial Securities Limited ("BFSL"), a broker and Depository Participant registered with Securities Exchange Board of India and offers various products/services related to Securities market (Securities market products/services). BFL merely facilitates display of data shared by BFSL on its webpage/mobile application. Such data received from BFSL, or any of its service providers is on “as is” basis. BFL does not make any representation or warranty, express or implied, regarding accuracy, completeness of such data displayed herein.

When you opt to avail the Securities market products/services of BFSL by clicking on the BFSL weblink/mobile app, you will be redirected to BFSL's web page/mobile app for initiation and completion of the transaction. You are supposed to exercise independent diligence by reading all the related documents carefully before deciding to invest in Securities market Products/services.

BFL is a Non-Banking Financial Company carrying the business of acceptance of deposits and providing lending solutions to Retail and Corporate customers. BFL does not offer nor advice on Securities market products/services and shall not be liable or responsible for any of your investment decision."

**Disclaimer: For Bajaj Financial Securities Limited

Investments in the securities market are subject to market risk, read all related documents carefully before investing.

Broking services offered by Bajaj Financial Securities Limited (Bajaj Broking). Reg Office: Bajaj Auto Limited Complex, Mumbai –Pune Road Akurdi Pune 411035. Corporate Office: Bajaj Financial Securities Limited, 1st Floor, Mantri IT Park, Tower B, Unit No 9 & 10, Viman Nagar, Pune, Maharashtra 411014. SEBI Registration No.: INZ000218931 | BSE Cash/F&O/CDS (Member ID:6706) | NSE Cash/F&O/CDS (Member ID: 90177) | DP registration No: IN-DP-418-2019 | CDSL DP No.: 12088600 | NSDL DP No. IN304300 | AMFI Registration No.: ARN –163403.

Details of Compliance Officer: Mr. Boudhayan Ghosh (For Broking/DP/Research) | Email: compliance_sec@bajajbroking.in | Contact No.: 020-4857 4486. For any investor grievances write to compliance_sec@bajajbroking.in/ compliance_dp@bajajbroking.in (DP related)

This content is for educational purpose only. Securities quoted are exemplary and not recommendatory.

Research Services are offered by Bajaj Broking as Research Analyst under SEBI Regn: INH000010043.

For more disclaimer, check here: https://www.bajajbroking.in/disclaimer

Promoter shares	Share	Category
Arjun Aggarwal	23,20,000 (12.08%)	Public Shareholding
Gaddam Venkata Ramana	4,71,600 (2.46%)	Shareholding of Promoter and Promoter Group
Rajesh Poddar	4,13,256 (2.15%)	Public Shareholding
Palloli Rama Chandra Reddy	3,56,715 (1.86%)	Public Shareholding
Sirisha Chintapalli	3,40,429 (1.77%)	Public Shareholding
Iswarya Gajjala	3,12,100 (1.62%)	Public Shareholding
Sudha Madhu Sudhan Reddy	3,09,753 (1.61%)	Public Shareholding
Anasuya Gorla	3,02,529 (1.58%)	Public Shareholding
Manchuri Manohar Reddy	3,01,000 (1.57%)	Public Shareholding
Rajendra Agrawal	3,02,087 (1.57%)	Public Shareholding
Surekha Naga Lakshmi Pendela	2,89,161 (1.51%)	Public Shareholding
Sreedevi Vemala	2,89,999 (1.51%)	Public Shareholding
Venkata Sesha Reddy Mudimela	2,33,891 (1.22%)	Public Shareholding
Govindamma Tallapareddy	1,96,696 (1.02%)	Public Shareholding
Satyanarayana Raju Bhupathiraju	1,32,145 (0.69%)	Shareholding of Promoter and Promoter Group
A Prabhakar Raju	95,476 (0.5%)	Shareholding of Promoter and Promoter Group
A Srinivasa Raju	94,386 (0.49%)	Shareholding of Promoter and Promoter Group
A Ranga Raju	74,243 (0.39%)	Shareholding of Promoter and Promoter Group
Alluri Anantha Laxmi	65,641 (0.34%)	Shareholding of Promoter and Promoter Group
Alluri Mythili	54,795 (0.29%)	Shareholding of Promoter and Promoter Group
P Kishore Raju	48,812 (0.25%)	Shareholding of Promoter and Promoter Group
Penmetsa Venkata Krishnam Raju	47,988 (0.25%)	Shareholding of Promoter and Promoter Group
Gaddam Srinivasarao	36,232 (0.19%)	Shareholding of Promoter and Promoter Group
Gaddam Venkata Rama	25,011 (0.13%)	Shareholding of Promoter and Promoter Group
V Varaprasada Rao	1,030 (0.01%)	Shareholding of Promoter and Promoter Group
Gaddam Balaji	993 (0.01%)	Shareholding of Promoter and Promoter Group
Kandula Murali Mohan	745 (0%)	Shareholding of Promoter and Promoter Group

VINEET LABORATORIES LTD

Vineet laboratories ltd share price update

Vineet Laboratories Ltd stock performance

₹29.32

₹30.21

₹22.37

₹42.19

Vineet Laboratories Ltd fundamentals

Vineet Laboratories Ltd financials

Particulars

Dec 25 (₹ value in crores)

Revenue

₹15.65

Operating expense

₹14.87

Net income

₹0.85

Net profit margin

5.43%

Earning per share

₹0.92

EBITDA

₹2.54

Effective tax rate

-3.65%

Particulars

Sep 25 (₹ value in crores)

Revenue

₹17.42

Operating expense

₹17.06

Net income

₹0.40

Net profit margin

2.29%

Earning per share

₹0.43

EBITDA

₹3.19

Effective tax rate

-8.1%

Particulars

Jun 25 (₹ value in crores)

Revenue

₹7.44

Operating expense

₹8.36

Net income

-₹0.87

Net profit margin

-11.69%

Earning per share

-₹0.94

EBITDA

₹0.33

Effective tax rate

4.44%

Particulars

Mar 25 (₹ value in crores)

Revenue

₹14.08

Operating expense

₹26.68

Net income

-₹10.53

Net profit margin

-74.78%

Earning per share

-₹11.42

EBITDA

-₹9.66

Effective tax rate

6.23%

Particulars

Dec 24 (₹ value in crores)

Revenue

₹18.10

Operating expense

₹23.80

Net income